Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetically”

278 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 278 results

Testing effectiveness (Phase 2)Looking for participantsNCT06378190
What this trial is testing

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

Who this might be right for
Refractory B-Cell LymphomaB-cell Lymphoma Recurrent
Instituto de Investigación Biomédica de Salamanca 27
Early research (Phase 1)WithdrawnNCT02055196
What this trial is testing

Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT02810951
What this trial is testing

FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Castle Creek Biosciences, LLC. 6
Early research (Phase 1)Study completedNCT02388594
What this trial is testing

A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)
University of Pennsylvania 14
Early research (Phase 1)Study completedNCT01766739
What this trial is testing

Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT07473154
What this trial is testing

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Who this might be right for
Diffuse Cutaneous Systemic SclerosisRheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+1 more
Quell Therapeutics Limited 16
Post-approval studies (Phase 4)Study completedNCT02351167
What this trial is testing

Genetically Informed Smoking Cessation Trial

Who this might be right for
Smoking Cessation
Washington University School of Medicine 822
Not applicableWithdrawnNCT01769911
What this trial is testing

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell Lymphoma+42 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01643330
What this trial is testing

Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Who this might be right for
Ischemic CardiomyopathyNon-ischemic CardiomyopathyHeart Failure+1 more
Celladon Corporation 250
Early research (Phase 1)Looking for participantsNCT07544992
What this trial is testing

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma, IDH-Wildtype
City of Hope Medical Center 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05864742
What this trial is testing

Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma Refractory
Peter MacCallum Cancer Centre, Australia 40
Testing effectiveness (Phase 2)UnknownNCT02693236
What this trial is testing

DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer

Who this might be right for
Esophagus Cancer
Affiliated Hospital to Academy of Military Medical Sciences 30
Early research (Phase 1)Study completedNCT00842634
What this trial is testing

Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV

Who this might be right for
HIVHIV Infections
University of Pennsylvania 12
Early research (Phase 1)Active Not RecruitingNCT02498912
What this trial is testing

Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors

Who this might be right for
Solid Tumors
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03628612
What this trial is testing

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Who this might be right for
Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell TherapyMultiple MyelomaDLBCL+2 more
Autolus Limited 500
Early research (Phase 1)Active Not RecruitingNCT02062827
What this trial is testing

Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma

Who this might be right for
Recurrent Glioblastoma MultiformeProgressive Glioblastoma MultiformeAnaplastic Astrocytoma or Gliosarcoma
University of Alabama at Birmingham 29
Testing effectiveness (Phase 2)UnknownNCT02134262
What this trial is testing

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

Who this might be right for
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Jichi Medical University 18
Early research (Phase 1)Active Not RecruitingNCT01683279
What this trial is testing

A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia

Who this might be right for
B Cell Leukemia
Seattle Children's Hospital 6
Early research (Phase 1)Ended earlyNCT06343376
What this trial is testing

Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+11 more
Roswell Park Cancer Institute 1
Not applicableEnrolling By InvitationNCT05627674
What this trial is testing

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

Who this might be right for
SmokingSmoking CessationTobacco Use Cessation
Washington University School of Medicine 915
Load More Results